Screening of the antileishmanial and antiplasmodial potential of synthetic 2-arylquinoline analogs
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Screening of the antileishmanial and antiplasmodial potential of synthetic 2-arylquinoline analogs ; volume:13 ; number:1 ; day:16 ; month:10 ; year:2023 ; pages:1-16 ; date:12.2023
Scientific reports ; 13, Heft 1 (16.10.2023), 1-16, 12.2023
- Urheber
-
Espinosa-Saez, Roger
Robledo, Sara M.
Pineda, Tatiana
Murillo, Javier
Zúñiga, César
Yañez, Osvaldo
Cantero-López, Plinio
Saez-Vega, Alex
Guzmán-Teran, Camilo
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-43805-4
- URN
-
urn:nbn:de:101:1-2024020809141608298281
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Espinosa-Saez, Roger
- Robledo, Sara M.
- Pineda, Tatiana
- Murillo, Javier
- Zúñiga, César
- Yañez, Osvaldo
- Cantero-López, Plinio
- Saez-Vega, Alex
- Guzmán-Teran, Camilo
- SpringerLink (Online service)
Ähnliche Objekte (12)
Synthetic optimization of cystobactamid analogs as antibiotics
Synthesis, antiplasmodial activity and in silico molecular docking study of pinocembrin and its analogs
Antiplasmodial activity of chloroquine analogs against chloroquine-resistant parasites, docking studies and mechanisms of drug action
Antiplasmodial and trypanocidal activity of violacein and deoxyviolacein produced from synthetic operons
Breast cancer stem cell selectivity of synthetic nanomolar-active salinomycin analogs
In vitro antiplasmodial activity of cepharanthine
Discovery of antifungal and antibacterial volatile natural products and synthetic drug analogs
The Discovery and Structure‐Activity Evaluation of (+)‐Floyocidin B and Synthetic Analogs
Novel Synthetic Clot Analogs for In-Vitro Stroke Modelling
Novel synthetic clot analogs for in-vitro stroke modelling
Genetic code engineering with methionine analogs for synthetic biotechnology
Rapid Screening of Antimicrobial Synthetic Peptides
Synthetic optimization of cystobactamid analogs as antibiotics
Synthesis, antiplasmodial activity and in silico molecular docking study of pinocembrin and its analogs
Antiplasmodial activity of chloroquine analogs against chloroquine-resistant parasites, docking studies and mechanisms of drug action
Antiplasmodial and trypanocidal activity of violacein and deoxyviolacein produced from synthetic operons
Breast cancer stem cell selectivity of synthetic nanomolar-active salinomycin analogs
In vitro antiplasmodial activity of cepharanthine
Discovery of antifungal and antibacterial volatile natural products and synthetic drug analogs
The Discovery and Structure‐Activity Evaluation of (+)‐Floyocidin B and Synthetic Analogs
Novel Synthetic Clot Analogs for In-Vitro Stroke Modelling
Novel synthetic clot analogs for in-vitro stroke modelling
Genetic code engineering with methionine analogs for synthetic biotechnology
Rapid Screening of Antimicrobial Synthetic Peptides
Synthetic optimization of cystobactamid analogs as antibiotics
Synthesis, antiplasmodial activity and in silico molecular docking study of pinocembrin and its analogs
Antiplasmodial activity of chloroquine analogs against chloroquine-resistant parasites, docking studies and mechanisms of drug action
Antiplasmodial and trypanocidal activity of violacein and deoxyviolacein produced from synthetic operons
Breast cancer stem cell selectivity of synthetic nanomolar-active salinomycin analogs
In vitro antiplasmodial activity of cepharanthine
Discovery of antifungal and antibacterial volatile natural products and synthetic drug analogs
The Discovery and Structure‐Activity Evaluation of (+)‐Floyocidin B and Synthetic Analogs
Novel Synthetic Clot Analogs for In-Vitro Stroke Modelling
Novel synthetic clot analogs for in-vitro stroke modelling
Genetic code engineering with methionine analogs for synthetic biotechnology